{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-019977","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.587708+00:00","generated_at":"2026-06-27T14:47:08.108632+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CytoDyn terminates CEO Nader Pourhassan; CFO Migliarese named interim president","bullets":["Board terminated CEO Nader Z. Pourhassan on Jan 24, 2022; he also resigned from the board.","Antonio Migliarese, current CFO, elected interim president; a committee will search for a permanent CEO.","Tanya Durkee Urbach elected Chairman of the Board; Scott Kelly remains CMO and director."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-019977","json":"https://secwatch.observer/filing/0001193125-22-019977.json","markdown":"https://secwatch.observer/filing/0001193125-22-019977.md","text":"https://secwatch.observer/filing/0001193125-22-019977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/d276339d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T14:47:08.108632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b3819eb6b","claim":"Nader Z. Pourhassan was terminated as President and Chief Executive Officer at CytoDyn Inc..","evidence_excerpt":"On January 24, 2022, the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”) terminated the employment of the Company’s President and Chief Executive Officer, Nader Z. Pourhassan, Ph.D., and removed him as an officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c580f98e2f","claim":"Antonio Migliarese was elected as interim President at CytoDyn Inc..","evidence_excerpt":"Also on January 24, 2022, the Board elected Antonio Migliarese interim President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"interim President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}